EUVIMEDEUVIMED entdecken
Open Access

Isotretinoin Treatment in Adolescence and Adult Height

Sigrun Alba Johannesdottir Schmidt, Therese Koops Grønborg, Sigrid Bjerge Gribsholt, Sinéad M Langan, Henrik Toft Sørensen, John S Barbieri

JAMA Dermatology · 2026

DOI: 10.1001/jamadermatol.2026.1197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, 2026. Verfasst von Sigrun Alba Johannesdottir Schmidt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology and Center for Population Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Isotretinoin, Acne Vulgaris, Dermatologic Agents, Body Height. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Isotretinoin is an effective treatment for moderate to severe acne, but concerns exist that exposure during adolescence could impair linear growth.

Objective

To examine whether isotretinoin use in adolescence is associated with reduced adult height. Design, Setting, and Participants This nationwide population-based cross-sectional study analyzed individuals eligible for military conscription in Denmark between January 1, 2001, and December 31, 2015, including all men and women volunteers. Conscription records were linked via unique personal identifiers to prospectively collected data from nationwide Danish registries. Individuals without a recorded height or with implausible height values were excluded. Data were analyzed from April 2025 to January 2026. Exposures Prior use of isotretinoin, oral tetracycline-class antibiotics, or topical acne therapies, ascertained from linked prescription records before outcome assessment. Individuals without prescribed acne treatment or hospital-diagnosed acne served as the reference group. Main Outcomes and Measures Adult height measured at conscription. Linear regression models adjusted for birth cohort and educational level were used to estimate mean differences in height. The predefined minimal clinically important difference was 5 cm or greater. Analyses were stratified by age at isotretinoin initiation and cumulative dose before conscription. Stunting was examined as a secondary outcome.

Results

The study included 379 196 individuals, of whom 368 338 were men (16 739 [4.5%] isotretinoin users) and 10 858 were women (278 [2.6%] isotretinoin users). Median age at conscription was 19.0 years (IQR, 18.7-20.0 years) among men and 19.2 years (IQR, 18.7-20.5 years) among women. The mean (SD) height at age 19 years was 180.4 (6.7) cm in men and 168.3 cm (5.9) in women. There was little variation in adult height across exposures. Compared with the reference group, in the isotretinoin group, the adjusted mean difference in height was 0.31 cm (95% CI, 0.20-0.41 cm) among men and 0.25 cm (95% CI, −0.47 to 0.96 cm) among women; both estimates were below the predefined minimal clinically important difference. Findings were consistent across analyses stratified by age at initiation, cumulative dose, and when using stunting as the outcome. Conclusions and Relevance In this nationwide cross-sectional study, isotretinoin for acne was not associated with reduced adult height. These findings may inform evidence-based decision-making when considering isotretinoin treatment during adolescence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinAcne VulgarisDermatologic AgentsBody HeightHumansCross-Sectional StudiesAdolescentFemaleMaleDenmarkYoung AdultAdultAge Factors

Substanzen

IsotretinoinDermatologic Agents

Autor:innen und Institutionen

  • Department of Clinical Epidemiology and Center for Population Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
  • Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, England.
  • Health Data Research UK, London, England.

Zitieren

APA

Schmidt, S. A. J., Grønborg, T. K., Gribsholt, S. B., Langan, S. M., Sørensen, H. T., & Barbieri, J. S. (2026). Isotretinoin Treatment in Adolescence and Adult Height. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2026.1197

Vancouver

Schmidt SAJ, Grønborg TK, Gribsholt SB, Langan SM, Sørensen HT, Barbieri JS. Isotretinoin Treatment in Adolescence and Adult Height. JAMA Dermatology. 2026. doi:10.1001/jamadermatol.2026.1197

BibTeX
@article{Schmidt2026,
  author = {Schmidt, Sigrun Alba Johannesdottir and Grønborg, Therese Koops and Gribsholt, Sigrid Bjerge and Langan, Sinéad M and Sørensen, Henrik Toft and Barbieri, John S},
  title = {Isotretinoin Treatment in Adolescence and Adult Height},
  journal = {JAMA Dermatology},
  year = {2026},
  doi = {10.1001/jamadermatol.2026.1197}
}
Kostenlos starten →